Revumenib

Revumenib (Revuforj) is a new oral medication for specific types of acute leukemia that have returned or haven't responded to earlier treatments. It works by targeting a protein called menin, which helps block a pathway that allows cancer cells with certain genetic changes to grow. This process helps immature cancer cells mature into healthy blood cells, potentially improving your condition. In this topic, you can learn more about how Revumenib works, who it's for, and what you can expect during treatment, helping you understand your care options.